FAGERHOLM, R.,
K. SPROTT,
T. HEIKKINEN,
J. BARTKOVA,
P. HEIKKILA,
K. AITTOMAKI,
J. BÁRTEK,
D. WEAVER,
C. BLOMQVIST,
H. NEVANLINNA
Overabundant FANCD2, alone and combined with NQO1, is a sensitive marker of adverse prognosis in breast cancer.
Annals of Oncology.
2013,
24(11),
2780-2785,
ISSN: 0923-7534,
PMID:
23897704,
PDF.
